| Financial Year |
March 31 2023 |
| Monetary Funds |
138,233,354.69 |
| Held-for-trading Financial Assets |
120,536,408.07 |
| Notes Receivable |
35,690,650.52 |
| Accounts Receivable |
332,888,125.70 |
| Advances to Suppliers |
32,405,084.99 |
| Other Receivables |
17,632,824.55 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
100,876,361.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,132,508.08 |
| Total Current Assets |
922,362,098.61 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
98,238,708.24 |
| Investment Properties |
2,966,296.01 |
| Fixed Assetes |
58,146,655.11 |
| Under-construction Projects |
13,423,298.59 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
185,814,904.00 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,547,067.43 |
| Deferred Income Tax Assets |
14,788,369.54 |
| Other Non-Current Assets |
17,207,423.90 |
| Sub-Total of Non-Current Assets |
441,757,603.61 |
| Total Assets |
1,364,119,702.22 |
| Short-Term Loans |
153,969,341.42 |
| Trading Financial liabilities |
-- |
| Notes Payable |
26,666,883.60 |
| Accounts Payable |
101,672,411.02 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,139,854.14 |
| Taxes Payable |
4,770,669.79 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,249,142.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
16,033,143.96 |
| Other Current Liabilities |
8,260,440.32 |
| Sub-Total of Current Liabilities |
358,616,623.39 |
| Long-term Loans |
15,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,586,678.27 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
31,293,518.48 |
| Total Liabilities |
389,910,141.87 |
| Paid-In Capital(Or Share Stock) |
174,292,973.00 |
| Capital Surplus |
315,080,801.50 |
| Surplus Reserve |
53,668,254.45 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
358,120,348.61 |
| Minority Stockholder's Interest |
73,482,823.74 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
900,726,736.61 |
| Owner's Equity（Stockholder's Equity） |
974,209,560.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,364,119,702.22 |
